Kurzübersicht für Lymphoid Enhancer-Binding Factor 1 (LEF1) Peptid (ABIN979264)
Target
LEF1
(Lymphoid Enhancer-Binding Factor 1 (LEF1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-LEF1 antibody (Catalog #: ARP32404_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
LEF1
Reaktivität: Human, Maus, Ratte
Wirt: Synthetic
BP, BI
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
LEF1
(Lymphoid Enhancer-Binding Factor 1 (LEF1))
Hintergrund
Lymphoid enhancer-binding factor-1 (LEF1) is a 48-kD nuclear protein that is expressed in pre-B and T cells. It binds to a functionally important site in the T-cell receptor-alpha (TCRA) enhancer and confers maximal enhancer activity. LEF1 belongs to a family of regulatory proteins that share homology with high mobility group protein-1 (HMG1).
Alias Symbols: DKFZp586H0919, FLJ46390, TCF1ALPHA, LEF-1, TCF10, TCF7L3
Protein Interaction Partner: CTNNB1,SMAD3,TLE1,ALX4,CDX1,CTNNB1,EP300,KPNA1,KPNA2,MITF,NLK,NOTCH1,PIAS4,PITX2,RUNX2,SMAD1,SMAD2,SMAD3,SMAD4,SUMO2,THOC4,TLE1,UBTF,ALX4,CTNNB1,EP300,Kpna1,Kpna2,MITF,NLK,NOTCH1,PIAS4,RUNX1,RUNX2,RUVBL1,SMAD2,SMAD3,SMAD4,SMAD7,THOC4,TLE1,UBTF